The Greater Sydney Commission has been tasked by the Premier to lead the accelerated delivery of key economic and innovation precincts across Greater Sydney including the Macquarie Park Innovation District.

Globally, modern slavery impacts nearly  46 million people. While for many this invokes images of crowded fashion industry sweatshops, the real picture is far more pervasive – touching every industry, and almost every supply chain. And in Australia, conservative estimates suggest 15,000 people are living and working in slave-like conditions.

Know that sinking feeling when annual performance review time comes around? Whether your version is a dull ticking-the-box process, an uncomfortable one-sided conversation, or somewhere in between, it’s rarely a fun experience. But according to Mark Lewis, Co-founder and CEO of Macquarie University Incubator resident Crewmojo, performance management doesn’t have to suck.

Australia may be a world leader in the MedTech sector due to its vibrant research environment but NSW’s capacity in the field is outstanding with the state being home to the largest medical technology sector in Australia, with 37% of the nation’s MedTech companies in the state.

As Macquarie Park transitions from traditional business park to a true innovation ecosystem, its leadership team is learning from – and strategising with – world leaders in innovation science through Boston’s MIT Regional Entrepreneurship Acceleration Program (REAP).

With two separate teams in this year’s CSIRO ON Accelerate cohort, Macquarie University is building quite the reputation for being a hothouse for tech innovation with impact.

AstraZeneca has committed $200m to its Macquarie Park manufacturing facility.  The investment follows $100m announced in 2017 and will go towards increasing the facility’s production capabilities, creating 250 jobs and increasing exports to $4.4bn over the next four years.